Grampians Health Ballarat

Ballarat, Victoria 3350

0 studies enrolling now · 3 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Atrial Fibrillation, High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke, Prevention of Stroke or Systemic Embolism

Studies at this site

• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain. — Completed